Vagal Stimulation, Through its Nicotinic Action, Limits Infarct Size and the Inflammatory Response to Myocardial Ischemia and Reperfusion

Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation

(2010) Weiwei Li et al.   HEART FAILURE REVIEWS

Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions

(2010) Gaetano M. De Ferrari et al.   HEART FAILURE REVIEWS

Early Short-Term Vagal Nerve Stimulation Attenuates Cardiac Remodeling After Reperfused Myocardial Infarction

(2010) Kazunori Uemura et al.   JOURNAL OF CARDIAC FAILURE

Differential regulation of TNF receptors by vagal nerve stimulation protects heart against acute ischemic injury

(2010) Rajesh G. Katare et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

(2009) Stephane Heymans et al.   EUROPEAN JOURNAL OF HEART FAILURE

FELASA Guidelines for the Accreditation of Health Monitoring Programmes and for Testing Laboratories involved in Health Monitoring

(2009) W Nicklas et al.   LABORATORY ANIMALS

Long term vagal stimulation in patients with advanced heart failure First experience in man

(2008) Peter J. Schwartz et al.   EUROPEAN JOURNAL OF HEART FAILURE